Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Vabysmo 120 mg/mL solution for injection {equilateral_black_triangle}

Active Ingredient:
faricimab
Company:  
Roche Products Limited See contact details
ATC code: 
S01LA09
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Audio/Video HCP Med Info
{arrow_left}
{arrow_right}
Audio Guide on Information for Patients - Guide to Vabysmo® (faricimab) for the Treatment of Diabetic Macular Oedema (DMO)

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.


Audio Guide on Information for Patients - Guide to Vabysmo® (faricimab) for the Treatment of Wet (Neovascular) Age-Related Macular Degeneration (AMD)

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.


Audio Guide on Information for Patients - Guide to Vabysmo® (faricimab) for the Treatment of Macular oedema secondary to Central Retinal Vein Occlusion (CRVO) or Branch Retinal Vein Occlusion (BRVO)

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.


Roche Products Limited
Company image
Address
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone
+44 (0)1707 366 000
Fax
+44 (0)1707 338 297
Medical Information Direct Line
+44 (0)800 328 1629
Customer Care direct line
+44 (0)800 731 5711
Medical Information e-mail
[email protected]
Medical Information Fax
+44 (0)1707 384555
WWW
http://www.roche.co.uk